Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06PVO
|
||||
| Former ID |
DNC007516
|
||||
| Drug Name |
4-phenyl-1-(1-phenylpropyl)piperidin-4-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528785] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H25NO
|
||||
| Canonical SMILES |
CCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O
|
||||
| InChI |
1S/C20H25NO/c1-2-19(17-9-5-3-6-10-17)21-15-13-20(22,14-16-21)18-11-7-4-8-12-18/h3-12,19,22H,2,13-16H2,1H3
|
||||
| InChIKey |
YUOJNJIUXXIUHY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528785] | |
| Nociceptin receptor | Target Info | Inhibitor | [528785] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [528785] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.